Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Is SRPT A Good Stock To Buy Right Now?’

gene, dna, organism, microarray, health, green, life, human genome, biotechnology, genetic diseases, disease, molecular biology, modern medical, micro structure,

Sarepta Therapeutics Inc (SRPT) Gets Off To A Running Start With Eteplirsen

Sarepta Therapeutics Inc (NASDAQ:SRPT) ­is one of the week’s biggest winners from the J.P. Morgan healthcare conference, with the company running up......(read more)
Most Advanced Countries in Medicine

5 Medical Tech Stocks You Should Be Investing In

The medical sector is growing rapidly and getting in on the ground floor with med tech can be highly profitable for smart investors, but how can you know......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Sarepta Therapeutics Inc (SRPT) Stock: “Eteplirsen Approval Controversy Rages On”

If you follow Sarepta Therapeutics Inc (NASDAQ:SRPT), you know about Eteplirsen. The treatment is designed to treat several diseases, including Duchenne......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

Summit Therapeutics PLC (ADR) (SMMT) Is Hot On Sarepta Therapeutics Inc (SRPT)’s DMD Tail

Duchenne’s Muscular Dystrophy (DMD) is a hot topic right now. The furor surrounding Sarepta Therapeutics Inc (NASDAQ:SRPT)’s Eteplirsen, which just......(read more)